Literature DB >> 23423227

A novel arthroscopic technique utilizing bone morphogenetic protein in the treatment of Kienböck disease.

Rebecca A Rajfer1, Jonathan R Danoff, Joshua A Metzl, Melvin P Rosenwasser.   

Abstract

Kienböck disease, first described in 1910, is osteonecrosis of the carpal lunate and has been associated with ulnar minus variance. Numerous joint leveling procedures have been developed for patients with ulnar-negative variance to decrease forces transmitted across the lunate. The basis of operative treatment is the presence or absence of advanced osteoarthritis associated with fragmentation of the carpal lunate and capitate descent. Bone morphogenetic proteins (BMPs) have been utilized successfully as adjunctive treatment in fracture healing and recently in the surgical treatment of a patient with Lichtman stage IIIA Kienböck disease. Arthroscopy is an available tool in assessing cartilage injury and coupled with the use of BMP may be of benefit in patients with ulnar-neutral or ulnar-negative wrists who have not progressed to severe arthritis and capitate descent. We report a novel arthroscopic technique in which a stage IIIA and IIIB carpal lunate osteonecrosis is treated by curettage and grafting with an admixture of autologous radial cancellous bone marrow graft and BMP-2.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23423227     DOI: 10.1097/BTH.0b013e3182712ba0

Source DB:  PubMed          Journal:  Tech Hand Up Extrem Surg        ISSN: 1089-3393


  2 in total

1.  Trans-4 Portal as a New Portal for Accessing the Lunate in Wrist Arthroscopy: a Cadaveric Study.

Authors:  Reza Shahryar-Kamrani; Hossein Saremi; Leila Oryadi-Zanjani; Mohammad Hossein Nabian; Azita Amoozadeh; Amir Hossein Moradi
Journal:  Iran Red Crescent Med J       Date:  2016-07-03       Impact factor: 0.611

2.  Treatment of Aseptic Necrosis of the Lunate Bone (Kienböck Disease) Using a Nickel-Titanium Memory Alloy Arthrodesis Concentrator: A Series of 24 Cases.

Authors:  Yongqing Xu; Chuan Li; Tianhua Zhou; Yongyue Su; Xiaoqing He; Xinyu Fan; Yueliang Zhu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.